key: cord-0689445-mjx55j44 authors: Filipe, M.D.; van Deukeren, D.; Kip, M.; Doeksen, A.; Pronk, A.; Verheijen, P.M.; Heikens, J.T.; Witkamp, A.J.; Richir, M.C. title: Impact of the COVID-19 pandemic on surgical breast cancer care in the Netherlands: a multicentre retrospective cohort study. date: 2020-08-07 journal: Clin Breast Cancer DOI: 10.1016/j.clbc.2020.08.002 sha: 322618981419987f7891eaab410f2f7ddb815bde doc_id: 689445 cord_uid: mjx55j44 BACKGROUND: Coronavirus disease 2019 (COVID-19) has put a strain on regular healthcare worldwide. In the Netherlands, the national screening programs, including breast cancer, were halted temporarily. This poses a challenge to breast cancer care, since approximately 40% of cases is detected through national screening. Therefore, the aim of this study is to evaluate the impact of the COVID-19 pandemic on surgical care of breast cancer patients in the Netherlands. METHODS: This multicenter retrospective cohort study investigated the impact of COVID-19 on breast cancer patients undergoing surgery from March 9(th) to May 17(th) 2020. Primary endpoints were the number of surgical procedures performed over time, tumor characteristics, type of surgery and route of referral. The secondary endpoint was the number postoperative complications over time. RESULTS: In total, 217 consecutive breast cancer patients requiring surgery were included. There was an overall decrease in the number of breast cancer patients undergoing surgical procedures. The most significant decline was seen in surgical procedures for T1-2 and N0 tumors. A decline in the number of referrals from both the national screening program and the general practitioners was observed. The number of postoperative complications remained stable over the study period. CONCLUSION: The temporary halt of the national screening program for breast cancer has resulted in fewer surgical procedures over time and a pronounced decrease in the lower tumor stages that were operated on. Coronavirus disease 2019 (COVID-19) is a highly infectious disease caused by acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which is responsible for the ongoing pandemic (1) . SARS-CoV-2 is mostly detected with polymerize chain reaction (PCR) from oropharyngeal swabs (2) . To date, over 11,000,000 cases and over 530,000 deaths have been confirmed worldwide (3) . COVID-19 pandemic has posed a challenge to regular healthcare (4) . Worldwide, measures to alleviate healthcare systems, such as suspension of elective surgeries, were taken (5) . In the Netherlands, similar policies were implemented regarding oncological care. If possible, elective surgeries were postponed and the national screening programs for breast and colorectal cancer were temporarily halted as from March 16 th 2020 (4, 6) . This has led to a concerning decline in breast cancer diagnoses (4, 7) . Breast cancer is the most common cancer and leading cause of cancer death in women worldwide (8) . In the Netherlands, the incidence of breast cancer is roughly 17.000 cases per year, of which approximately 40% is detected through the national screening program (9, 10) . Surgical resection with or without radiotherapy and/or systemic treatment of the primary tumor is the treatment of choice in patients with new onset breast cancer (11) (12) (13) . The measures taken to alleviate health care systems due to COVID-19 strongly affect breast cancer patients, especially due to postponed surgeries and halted national screening (4, 6) . Recently, the number of breast cancer diagnoses have been reduced up to 50%, which can be attributed to the temporary halt of the national screening program and/or to fewer referrals from general practitioners (GP) (4). However, the consequences for surgical care for breast cancer are unknown. Therefore, the aim of this study is to determine the impact of the COVID-19 pandemic on the surgical demand for breast cancer. Included patients could be tested for COVID-19 prior to or during admission to the hospital. In addition, COVID-19 related symptoms could be registered. Reverse transcriptase PCR for SARS-CoV-2 was used in all centers, according to European guidelines for analysis (2) . The genes used for analysis were the RdRP gene, E gene, and the N gene. The E gene assay was used first, followed by a confirmatory testing with the RdRp gene assay In this study, COVID-19 related symptoms were defined as cough, fever, fatigue, chest pain, dyspnoea and/or other flu-like symptoms. The primary endpoints were the number of surgical procedures for breast cancer, TNM classification prior to operation, type of surgical procedure and initial referral (i.e. due to the national screening program or by the GP). The secondary endpoint was the number of postoperative complications. Additionally, we aimed to determine which factors influence the risk of postoperative complications. Surgical procedures were defined as breast conserving therapy (BCT), mastectomy (with and without immediate reconstruction) and other types of procedure (i.e. lymph node dissection, lymph node biopsy, re-excision, scar-excision). The general condition of patients prior to surgery was assessed with the American Society of Anesthesiologists (ASA) classification (14) . The severity of the complications were classified according to the Clavien-Dindo classification (15) . Major complications were defined as Clavien-Dindo class III or higher. Tumors were categorized according to the tumor, node and metastasis (TNM) classification system (16) . Phyllodes tumors were not graded according to the TNM classification (17) . J o u r n a l P r e -p r o o f Furthermore, radiotherapy, anti-hormonal therapy, immune therapy and chemotherapy were classified as adjuvant or neo-adjuvant therapy. The number of comorbidities was based on the history of cardiovascular disease, pulmonary disease, renal disease and/or diabetes. Descriptive statistics were used to describe patient and treatment characteristics. Continuous data were reported as means plus standard deviation (SD), or as medians and interquartile range (IQR), depending on the distribution. Student's t test or Mann-Whitney U test was used to determine difference between groups, depending on the distribution. Differences between categorical data were assessed with the Chi-Square test. Multiple imputation by chained equations (MICE) using the MICE package in R was performed for imputing missing data. Missing data were compared to non-missing data to determine whether data were missing at random. The imputation was repeated ten times, followed by application of Rubin's rule to combine parameter estimates and standard errors (18, 19) . Imputed data were compared later to the complete cases to determine the validity of the imputation model. Imputed data were used in the analyses. Two-sided P-values below 0.05 were considered statistically significant. Multivariate logistic regression analyses was performed to study the risk of the development of complications in patients who had undergone surgery. Odds ratio (OR) and 95% confidence intervals (CI) were used to quantify the risk. Possible confounding factors and effect modifiers were age, body mass index (BMI), ASA classification, type of breast surgery, number of comorbidities, TNM classification, week in which surgery was performed, symptoms associated with COVID-19 and testing for COVID-19. All calculations were performed using RStudio 1.2.5001 (with R version: x64 3.6.3). Visualization of plots was performed using the ggplot2 package. In total, 217 consecutive breast cancer patients with a mean age of 62 years were included in this study. The majority of patients was diagnosed with T1-2 breast cancer (81.7%) without lymph node involvement (N0) (71%). Furthermore, ten patients were diagnosed with a phyllodes tumor. None of the included patients was diagnosed with metastatic disease. Neoadjuvant and adjuvant treatment was involved in 61 (28.1%) and 170 (78.3%) patients, respectively. One-hundred-thirty-nine (64.1%) patients underwent BCT. Twenty-one patients were tested for COVID-19 (9.7%) and none of them were tested positive. Complications occurred in 18 patients, of which eight (3.7%) patients suffered from major complications ( Table 1) . The number of different types of breast surgery performed from March 9 th to May 17 th are presented Figure 1 . There was an overall decline in the total number of surgical procedures performed which was most pronounced after week six of the study. However, in the last two weeks (week 9 and 10) there appeared to be a slight increase in the total number of breast cancer surgeries performed. BCT procedures declined steady over time, except for the slight rise in the last two weeks of the study. At the same time, mastectomy and other types of breast surgery remained stable over time. There were no significant differences in the proportion of surgical procedures performed between the weeks (p=0.173). The route of referral for the included breast cancer patients is presented in Figure 2 . This includes the number of patients referred by the GP or due to national screening. In the study period, there was an overall decrease in the number of breast cancer patients requiring surgery who were originally diagnosed due to the national screening program. At the same time, the number of patients who were referred by the GP declined sharply after the week 6 th week of the study. However, this number increased again after the 8 th week. The number of breast cancer patients with T1 and N1 tumors gradually declined over the weeks, while the decrease of patients with N0 tumors started after the 6 th week of the study. Other T stages and N stages remained stable over time (Figure 3 ). (11) (12) (13) . This confirms previous findings that show that there are nationwide fewer breast cancer diagnosis during the COVID-19 epidemic (4). Furthermore, this decrease was especially prominent six weeks after the temporary stop of the national screening program, which equals week seven in our study period. In the Netherlands, treatment (neo-adjuvant, radiotherapy and/or surgery) is normally required within six weeks after initial cancer diagnosis (25) . Therefore, a decline in the number of surgical procedures can be expected six weeks after halting national screening. Moreover, the current study showed that there was not only a decrease of breast cancer patients who were referred through national screening program but also in patients referred by the GP. This was because in the beginning of the pandemic the Dutch government discouraged patients to visit the GP unless absolutely necessary. While the patients referred by the GP increased steadily in the last weeks of the study, the number of patients referred due to The current study demonstrated a decline in T1-2 and N0 tumors, which can be attributed to the temporary halt of the Dutch national screening program. This is not surprising since the majority of screening detected breast cancers is diagnosed at an early stage (27) . However, we do not suspect that the temporary halt of the breast cancer screening program has a significant impact on long-term outcomes since most breast cancers that are discovered by the screening program are early staged breast cancers that will develop slowly. Consequently, we do not suspect that there will be an increase in the number of higher staged breast cancers since the breast cancer screening program stopped for only 4 months. This confirms previous findings from the Netherlands Comprehensive Cancer Organisation, IKNL that show that there are nationwide fewer breast cancer diagnosis during the COVID-19 pandemic (4). The higher T and N stages appear to have remained relatively stable over time. The decrease in T1-2 and N0 tumors also explains the decrease in BCT performed, since BCT is the preferred treatment over mastectomy in these tumor stages (11) (12) (13) . Despite the relatively small risk of postoperative complications in breast cancer surgery, many studies recommend not to perform or to postpone these procedures (23, 24, 28, 29) . However, no rise in postoperative complications in patients undergoing breast cancer surgery during the COVID-19 pandemic has been observed in this study. Multivariate analysis showed that patients undergoing mastectomy and patients with multiple comorbidities were at increased risk of developing postoperative complications. This is in line with previous studies reporting that a significantly higher complication rate is seen in patients undergoing mastectomies and in patients with comorbidities (28, 29) . This study has some limitations. Firstly, the number of included patients was relatively small. Therefore, the number T3-4 tumors was low, which makes the recognition of patterns for this Coronavirus disease 2019 (COVID-19): current status and future perspectives Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands Cancer guidelines during the COVID-19 pandemic Handvat voor chirurgische ingrepen tijdens Corona-crisis COVID 19 en borstkanker Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries Burden of early, advanced and metastatic breast cancer in The Netherlands A modelling study to evaluate the costs and effects of lowering the starting age of population breast cancer screening Effect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer Survival is Better After Breast Conserving Therapy than Mastectomy for Early Stage Breast Cancer: A Registry-Based Followup Study of Norwegian Women Primary Operated Between 10 year survival after breast-conserving surgery plus radiotherapy compared with mastectomy in early breast cancer in the Netherlands: a population-based study. The LancetOncology American Society of Anesthesiologists Physical Status Classification System in not a risk classification system Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey A Pictorial Review of Changes in the BI-RADS Fifth Edition Phyllodes tumours of the breast: a consensus review Characterizing and Managing Missing Structured Data in Electronic Health Records: Data Analysis Multiple imputation with multivariate imputation by chained equation (MICE) package Novel Coronavirus 2019 (2019-nCoV) Infection: Part I -Preparedness and Management in the Pediatric Intensive Care Unit in Resource-limited Settings The 3 Steps Needed to End the COVID-19 Pandemic: Bold Public Health Leadership, Rapid Innovations, and Courageous Political Will. JMIR public Heal Surveill Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency Impact of the Coronavirus (COVID-19) pandemic on surgical practice -Part 1 Impact of the Coronavirus (COVID-19) pandemic on surgical practice -Part 2 (surgical prioritisation) Dutch Ministry. Campaign to encourage patients to visit the general practioner during COVID-19 in order to keep up with cancer diagnoses Morbidity and Mortality Following Breast Cancer Surgery in Women Postoperative Complications After Breast Cancer Surgery are Not Related to Age Nationwide populationbased study of trends and regional variation in breast-conserving treatment for breast cancer Regional variation in breast cancer treatment in the Netherlands and the role of external peer review: a cohort study comprising 63,516 women J o u r n a l P r e -p r o o f Highlights • The COVID-19 pandemic has caused a significant reduction of breast cancer patients undergoing surgery • Reduction of the number of breast cancer surgical procedures performed were due to the temporary suspension of the national screening program and the fewer referrals from the general practitioner • The number of breast cancer patients with higher staged tumors that underwent a surgical procedure remained stable while the number of patients undergoing surgical procedures with lower staged tumors dropped significantly. Coronavirus disease 2019 (COVID-19) has an enormous impact on regular healthcare worldwide. Measures taken to reduce the spreading of COVID-19 include social distancing but also a temporary stop of the national screening programs. Measures taken to reallocate hospital resources in favor of COVID-19 care include postponing (oncological) surgical procedures. Another reason for postponing (oncological) surgical procedures was out of the fear of increased risk of postoperative complications. Since surgery one of the most important factor for the treatment of breast cancer, the aim of this study was to determine the impact of the COVID-19 pandemic on surgical care for breast cancer.The current multicenter observational study showed that there was a decrease in the number of surgical procedures performed due to breast cancer. This reduction was not only due to the suspension of the national screening program but also due to fewer referrals from the general practitioner. The decrease in the weekly number of surgical procedures performed was most pronounced in the lower staged breast cancer tumors. Additionally, none of the breast cancer patients undergoing surgery tested positive for COVID-19. However, only patients with COVID-19 like symptoms (such as fever cough and dyspnea) were tested for COVID-19. Yet, multivariate analysis showed that there was no increase in postoperative complications over time. This means that even if some of the untested breast cancer patients were actually positive for COVID-19, they were not at an increased risk of developing postoperative complications since the number of postoperative remained stable over the study period.